CLINICAL STUDIES ON HAPA-B
スポンサーリンク
概要
- 論文の詳細を見る
HAPA-B, a new aminoglycoside, was evaluated clinically in 9 patients aged 34-70 years with respiratory tract infection (5 cases) and with urinary tract infection (4 cases).A daily dose of HAPA-B was 200mg by intramuscular injection twice a day and duration of HAPA-B therapy was for 14 days.<BR>The results were as follows, <BR>1. Clinical response to HAPA-B therapy of respiratory tract infection was good in 3 cases, fair in one case and poor in one case and that of urinary tract infection was good in 3 cases and poor in one case.<BR>Efficacy rate was 67%.<BR>2. As a side effect, worsening of proteinuria (±→++) was shown in one case.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.